Jukka Westermarck and his group received the Elias Tillandz -prize
Prof. Jukka Westermarck and his group received the Elias Tillandz -prize for the best publication of the year for his ground-breaking study on that reveals the druggability of type-2A phosphatase, which has been largely regarded as a non-druggable cancer target. Link to study.
Warmest congratulations to the whole team!
Read more:
Recent Posts
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026
- Rector Widen Visited Our Centre Åbo Akademi University Rector, Gunilla Widén, visited our Centre on Wednesday, February 25th, to learn Read moreFebruary 27, 2026
- Laura Elo is awarded the Leif C. Groop Award for outstanding research on type 1 diabetesLaura Elo a group leader at Turku Bioscience is awarded the Leif C. Groop Award Read moreFebruary 23, 2026
- Finnish Cultural Foundation Awards Funding to Turku Bioscience ResearchersWe are pleased to announce recent funding from The Finnish Cultural Foundation: Congratulations to all Read moreFebruary 16, 2026
- Newly discovered gut microbial molecules in infancy may influence the risk of type 1 diabetesAn international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important Read moreJanuary 20, 2026
- Turku Bioscience Centre Is Recruiting New Research LeadersTurku Bioscience Centre is currently inviting applications for two key research positions that will strengthen Read moreJanuary 13, 2026